April 25, 2022 --- International Forum on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All was held in Diayutai State Guesthouse, Beijing, China.  

This forum was co-hosted by China International Development Cooperation Agency (CIDCA), National Health Commission (NHC), and National Administration of Traditional Chinese Medicine (NATCM). State Councilor and Foreign Minister Wang Yi read President Xi Jinping's congratulatory letter to the forum and delivered a speech.  

With the support of China Chamber of Commerce for Import & Export of Medicines & Health Products, Ustar was invited as one of the five enterprises attending this forum, and exhibited molecular point-of-care diagnostic products for malaria. 

Senegalese President Macky Sall, Zimbabwean President Emmerson Mnangagwa, Comoros President Azali Assoumani, Madagascar's President Andry Rajoelina, Cambodian Prime Minister Samdech Techo Hun Sen, Lao Prime Minister Phankham Viphavanh, and WHO Deputy Director-General Zsuzsanna Jakab sent congratulatory video clips to the forum respectively. Ms. Tu Youyou, a Nobel laureate in physiology or medicine, introduced the significance of artemisinin in helping the global campaign against malaria in a video.

Representatives from relevant Chinese government departments, diplomatic envoys of relevant countries to China, representatives of international organizations in China attended the forum, and visited the exhibition on the 50th Anniversary of the Discovery of Artemisinin and on Building a Global Community of Health for All.

 Luo Zhaohui, Chairman of the China International Development Cooperation Agency (CIDCA) Read Malaria Diagnostic Display 

EasyNAT®  Molecular Testing Platform for Malaria

April 25 marks the World Malaria Day. Malaria is a life-threatening challenge globally. It is considered as one of the three most serious infectious diseases by WHO. Accurate and efficient diagnostic methods are of great significance for the prevention and control of malaria.

Considering that traditional malaria testing has its limitations, including diagnostic omissions, errors and delays, Ustar has developed an automatic and integrated point-of-care testing platform that detects nucleic acid of Plasmodium, improving Plasmodium detection rate and contributing to global anti-malaria practices. With a single click on the touchscreen, user can get result automatically reported by the system in as fast as 49 minutes, realizing "sample in, result out" without extra manual operation. The system is intended for fast, accurate and qualitative detection of five types of Plasmodia nucleic acids in human plasma, whole blood, and fingertip blood samples. It is of high sensitivity with the limit of detection (LOD) ≤60 parasites/mL.

Molecular point-of-care testing is an accurate, fast testing approach of high sensitivity and specificity, particularly suitable for low-density Plasmodium infection. Based on cross priming amplification technology, EasyNAT® Malaria Assay has good prospects due to its fast, simple, accurate and instrument-free features.

Ustar Biotechnologies (Hangzhou) Ltd, a leading point-of-care molecular diagnosis provider for tuberculosis, COVID-19, malaria and other major communicable diseases. With continuous investment in research and development, we aim to provide more affordable and better solutions for the prevention and control of human communicable diseases, as we stated as our core value: molecular testing, anywhere!